Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFBK
3626
DELISTED
Northfield Bancorp
NFBK
| $135K | ﹤0.01% |
14,289
-21,475
| -60% | -$188K |
|
|
SKYT
3627
DELISTED
SkyWater Technology
SKYT
| $135K | ﹤0.01% |
17,681
-3,798
| -18% | -$33K |
|
|
IFN
3628
Aberdeen India Fund
IFN
$504M
| $135K | ﹤0.01% |
6,786
+154
| +2% | +$2.8K |
|
3629
inTEST
INTT
$177M
| $135K | ﹤0.01% |
13,658
+680
| +5% | +$7.27K |
|
|
OBE
3630
Obsidian Energy
OBE
$662M
| $135K | ﹤0.01% |
18,026
-15,616
| -46% | -$122K |
|
|
RPC
3631
Ridgepost Capital
RPC
$991M
| $135K | ﹤0.01% |
15,892
-23,937
| -60% | -$191K |
|
3632
Innodata
INOD
$2.04B
| $135K | ﹤0.01% |
9,087
-9,244
| -50% | -$96.1K |
|
|
THRD
3633
DELISTED
Third Harmonic Bio
THRD
| $134K | ﹤0.01% |
10,302
-5,730
| -36% | -$70.9K |
|
3634
CarParts.com
PRTS
$54.7M
| $134K | ﹤0.01% |
13,389
-3,523
| -21% | -$42.9K |
|
3635
Fossil Group
FOSL
$318M
| $133K | ﹤0.01% |
92,602
-36,700
| -28% | -$41.7K |
|
3636
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $133K | ﹤0.01% |
1,900
| – | – |
|
3637
Kura Sushi USA
KRUS
$593M
| $133K | ﹤0.01% |
2,104
-3,200
| -60% | -$323K |
|
3638
Xponential Fitness
XPOF
$211M
| $133K | ﹤0.01% |
8,494
-61,949
| -88% | -$764K |
|
|
DENN
3639
DELISTED
Denny's
DENN
| $132K | ﹤0.01% |
18,589
-27,629
| -60% | -$213K |
|
3640
Celcuity
CELC
$4.52B
| $132K | ﹤0.01% |
8,029
-4,815
| -37% | -$80.6K |
|
3641
Real Brokerage
REAX
$466M
| $131K | ﹤0.01% |
32,260
-66,752
| -67% | -$280K |
|
|
CGAU
3642
Centerra Gold
CGAU
$4.15B
| $131K | ﹤0.01% |
19,486
-32,636
| -63% | -$214K |
|
3643
Titan Machinery
TITN
$445M
| $131K | ﹤0.01% |
8,235
-17,519
| -68% | -$366K |
|
3644
Fidelity D&D Bancorp
FDBC
$317M
| $130K | ﹤0.01% |
2,979
-757
| -20% | -$34.8K |
|
3645
AudioEye
AEYE
$75M
| $130K | ﹤0.01% |
+7,393
| New | +$131K |
|
3646
Kornit Digital
KRNT
$791M
| $130K | ﹤0.01% |
8,876
-10,262
| -54% | -$158K |
|
3647
Aura Biosciences
AURA
$826M
| $129K | ﹤0.01% |
17,113
-8,281
| -33% | -$60.7K |
|
|
IIF
3648
Morgan Stanley India Investment Fund
IIF
$220M
| $129K | ﹤0.01% |
4,000
| – | – |
|
3649
Neurogene
NGNE
$712M
| $129K | ﹤0.01% |
3,543
-8,457
| -70% | -$298K |
|
3650
Acrivon Therapeutics
ACRV
$74M
| $128K | ﹤0.01% |
22,033
+709
| +3% | +$5.71K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.